Alkermes' Corporate Presentation to be Webcast at the 30th Annual J.P. Morgan Healthcare Conference

DUBLIN (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the 30th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2012, at 9:00 a.m. PST (12:00 p.m. EST/5:00 p.m. GMT) from the Westin St. Francis Hotel in San Francisco. The presentation may be accessed under the Investor tab on and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression.Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts and manufacturing facilities in Athlone, Ireland; Gainesville, Georgia; and Wilmington, Ohio. For more information, please visit Alkermes' website at .

Source: Alkermes plc

Alkermes plc
Eva Stroynowski, +1-781-609-6823
Corporate Communications

distribué par

Ce noodl a été diffusé par Alkermes Inc. et initialement mise en ligne sur le site http://www.alkermes.com. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-03 14:44:19 PM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.